- Home
- NHI vs INDV Comparison
NHI vs INDV Comparison
Compare NHI & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHI
- INDV
- Stock Information
- Founded
- NHI 1991
- INDV 1994
- Country
- NHI United States
- INDV United States
- Employees
- NHI N/A
- INDV N/A
- Industry
- NHI Real Estate Investment Trusts
- INDV Biotechnology: Pharmaceutical Preparations
- Sector
- NHI Real Estate
- INDV Health Care
- Exchange
- NHI Nasdaq
- INDV Nasdaq
- Market Cap
- NHI 3.7B
- INDV 4.1B
- IPO Year
- NHI 1991
- INDV N/A
- Fundamental
- Price
- NHI $80.14
- INDV $33.40
- Analyst Decision
- NHI Buy
- INDV Strong Buy
- Analyst Count
- NHI 4
- INDV 4
- Target Price
- NHI $84.00
- INDV $32.50
- AVG Volume (30 Days)
- NHI 206.3K
- INDV 2.6M
- Earning Date
- NHI 11-06-2025
- INDV 10-30-2025
- Dividend Yield
- NHI 4.62%
- INDV N/A
- EPS Growth
- NHI 8.88
- INDV 111.35
- EPS
- NHI 3.17
- INDV 0.98
- Revenue
- NHI $357,572,000.00
- INDV $1,180,000,000.00
- Revenue This Year
- NHI $4.68
- INDV N/A
- Revenue Next Year
- NHI $10.60
- INDV $3.06
- P/E Ratio
- NHI $25.13
- INDV $34.12
- Revenue Growth
- NHI 8.40
- INDV N/A
- 52 Week Low
- NHI $65.13
- INDV $7.62
- 52 Week High
- NHI $80.56
- INDV $33.64
- Technical
- Relative Strength Index (RSI)
- NHI 68.89
- INDV 72.76
- Support Level
- NHI $77.48
- INDV $31.23
- Resistance Level
- NHI $79.08
- INDV $33.64
- Average True Range (ATR)
- NHI 1.54
- INDV 1.24
- MACD
- NHI 0.34
- INDV 0.01
- Stochastic Oscillator
- NHI 89.83
- INDV 94.12
About NHI National Health Investors Inc.
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.